ID   NCC-DDLPS4-C1
AC   CVCL_B3TQ
DR   Wikidata; Q110433083
RX   PubMed=34834427;
WW   Provider; BizCom; -; https://en.cellline.jp/product/ncc-ddlps4-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 72.5 hours (PubMed=34834427).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): PubMed=34834427
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D21S11: 29,30
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
RX   PubMed=34834427; DOI=10.3390/jpm11111075; PMCID=PMC8618493;
RA   Tsuchiya R., Yoshimatsu Y., Noguchi R., Sin Y., Ono T., Akiyama T.,
RA   Hirose T., Iwata S., Yoshida A., Ohtori S., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-DDLPS4-C1: a novel
RT   patient-derived cell line of dedifferentiated liposarcoma.";
RL   J. Pers. Med. 11:1075.1-1075.15(2021).
//